Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 603-373-3 | CAS number: 129909-90-6
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
Section 7.9.3 - Specific investiations: other:
KS - mech.rat. Croutch & Christenson, 1999. KL.1;
SS - mech. in vitro. Freyberger, 1998. KS.2
Additional information
The mechanistic study (Croutch & Christenson, 1999) further characterises amicarbazone’s effects on the thyroid. In this study no treatment related effects were observed on the thyroid gland weight or microscopic changes observed in this organ at any treatment level. Thyroid to blood ratios of125I in treated groups were comparable throughout all treatment groups to the respective concurrent control groups, indicating the increase in thyroid hormones were most likely not due to increased synthesis, but rather differences in thyroid hormones being metabolised at another site. The liver is implicated as the extra-thyroidal site based on increased liver weights and UDP-glucuronosyltransferase activity.
The results of the in vitro mechanistic study (Freyberger, 1998) support the conclusion that MKH 3586 does not affect the major enzymes involved in the synthesis or regulation of thyroid hormones, and strengthens the findings of thein vivosub-chronic mechanistic study which indicated that amicarbazone is conjugated by UDP- glucuronosyl transferase. This enzyme is also responsible for the conjugation of T3 / T4, therefore it would appear that amicarbazone competes for this enzyme with these thyroidal hormones. As a result less UDP- glucuronosyl transferase is available to conjugate T3 / T4, with serum levels increasing. This leads to hypertrophy of the liver, through the up regulation of UDP- glucuronosyl transferase.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
